Interim CFO Appointed Vancouver, British Columbia–(Newsfile Corp. – April 30, 2025) – Mark Jarvis, CEO of Shoal Point Energy Ltd. (CSE: SHP) (“The Company”), announced today that the Board of the Company has accepted the resignation of Natasha Tsai as Chief Financial Officer of the Company, effective at today’s date. …
Read More »Central Puerto Announces Reporting Date for the First Quarter 2025 Financial Results Conference Call and Webcast
Buenos Aires, Argentina–(Newsfile Corp. – April 30, 2025) – Central Puerto S.A (NYSE: CEPU) (“Central Puerto” or the “Company”) one of the largest private sector power generation companies in Argentina, will issue a press release announcing its First Quarter results on May 12, 2025. Mr. Fernando Bonnet, Chief Executive Officer, …
Read More »Centaurus Energy Provides Update on 2024 Annual Financial Statement Filings
Calgary, Alberta–(Newsfile Corp. – April 30, 2025) – Centaurus Energy Inc. (TSXV: CTA) (OTC Pink: CTARF) (“Centaurus” or the “Company”) provides this default announcement indicating Centaurus’s anticipated failure to file its annual financial statements for the year ended December 31, 2024 and related management discussion and analysis and certifications (collectively, …
Read More »First Phosphate Files Form 15F to Voluntarily Terminate SEC Reporting Obligations
Saguenay, Quebec–(Newsfile Corp. – April 30, 2025) – First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) (“First Phosphate” or the “Company”) announces that it has voluntarily filed a Form 15F with the United States Securities and Exchange Commission (the “SEC”) today for the purpose of terminating the registration of …
Read More »Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
Northvale, New Jersey–(Newsfile Corp. – April 30, 2025) – Elite Pharmaceuticals, Inc. (OTCQB: ELTP) (“Elite” or the “Company”), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite’s generic version of Percocet® (oxycodone hydrochloride and acetaminophen tablets, USP CII) 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets. Oxycodone …
Read More »NuGen Announces Release of 2024 Annual Financial Results
Toronto, Ontario–(Newsfile Corp. – April 30, 2025) – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen”) a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of 2024 Annual Financial Results. Annual Financial Statements Reflect Commercial Ramp Up The orders announced previously in …
Read More »Ionik Announces Record Fourth Quarter and Fiscal 2024 Results
Record Fiscal 2024 Revenue of $179 million – Growth of 28% over previous 12 months Record Fiscal 2024 Adjusted EBITDA1 of $23 million – 34% growth compared to $17.2 million in the prior 12 months Record Quarterly Adjusted EBITDA1 of $7.3 million in Q4 – Year-over-year growth of 32% and …
Read More »Great Pacific Gold Corp. Engages ICP Securities Inc. for Automated Market Making Services
Vancouver, British Columbia–(Newsfile Corp. – April 30, 2025) – Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) (“Great Pacific Gold,” “GPAC,” or the “Company”) has engaged the services of ICP Securities Inc. (“ICP”) to provide automated market making services, including use of its proprietary algorithm, ICP Premium™, in …
Read More »Wilton Resources Inc. Announces Amendment to Outstanding 833,333 Warrants
Calgary, Alberta–(Newsfile Corp. – April 30, 2025) – Wilton Resources Inc. (TSXV: WIL) (the “Corporation”) announces that it submitted an application to the TSX Venture Exchange (the “Exchange”) to amend the term of 833,333 common share purchase warrants (the “Warrants”) issued to subscribers as part of the Corporation’s private placement financing which closed …
Read More »Wilton Resources Inc. Announces Amendment to Outstanding 2,791,767 Warrants
Calgary, Alberta–(Newsfile Corp. – April 30, 2025) – Wilton Resources Inc. (TSXV: WIL) (the “Corporation”) announces that it submitted an application to the TSX Venture Exchange (the “Exchange”) to amend the term of 2,791,767 common share purchase warrants (the “Warrants”) issued to subscribers as part of the Corporation’s private placement financing which closed …
Read More »
Matribhumi Samachar English